Cargando…
Vulva cancer in Ghana – Review of a hospital based data
• Seventy- 5% of vulvar cancer cases present with advance disease. • Definitive radiotherapy/chemoradiation is the main stay of treatment. • One third of patients default treatment. • Five year survival following radiotherapy was 36.7%.
Autores principales: | Dadzie, Mary Ann, Aidoo, Charles A., Vanderpuye, Verna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382029/ https://www.ncbi.nlm.nih.gov/pubmed/28409179 http://dx.doi.org/10.1016/j.gore.2017.03.015 |
Ejemplares similares
-
Challenges to development of cervical and breast cancer program development in post conflict Liberia: Presentation prepared for African First Ladies' Conference, 10th SCCA Conference, Addis Ababa, Ethiopia 2016
por: Beddoe, Ann Marie
Publicado: (2017) -
Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges
por: Johnston, Carolyn, et al.
Publicado: (2017) -
Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand
por: Termrungruanglert, Wichai, et al.
Publicado: (2017) -
Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery
por: LaVigne, Anna W., et al.
Publicado: (2017) -
Cervical cancer screening and treatment in Uganda
por: Nakisige, Carolyn, et al.
Publicado: (2017)